IL-33 levels are associated with poor prognosis in several cancers due to its contribution to the development of immunosuppressive tumor microenvironment by affecting tumor stromal cells through the activation of carcinoma-associated fibroblasts (CAF) and the induction of VEGF expression [144,145]. The gene discussed is VEGFA; the disease is neoplasm.